Signature Financial Management’s Pfizer PFE Stock Holding History

Signature Financial Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$920K	Sell	22,228 -52,633	-70%	-$2.18M	0.22%	49
2018 Q3	$3.13M	Sell	74,861 -118	-0.2%	-$4.54K	0.55%	30
2018 Q2	$2.58M	Sell	74,979 -7,595	-9%	-$260K	0.55%	32
2018 Q1	$2.78M	Buy	82,574 +56,131	+212%	+$1.93M	0.58%	31
2017 Q4	$908K	Sell	26,443 -9,391	-26%	-$320K	0.25%	49
2017 Q3	$1.11M	Buy	35,834 +3,479	+11%	+$112K	0.34%	46
2017 Q2	$1.03M	Buy	32,355 +6,086	+23%	+$192K	0.32%	48
2017 Q1	$852K	Sell	26,269 -128	-0.5%	-$4.04K	0.27%	53
2016 Q4	$812K	Sell	26,397 -1,364	-5%	-$41.6K	0.31%	54
2016 Q3	$894K	Buy	27,761 +410	+1%	+$13.7K	0.36%	47
2016 Q2	$915K	Buy	27,351 +1,385	+5%	+$44.2K	0.43%	39
2016 Q1	$731K	Sell	25,966 -1,498	-5%	-$42.8K	0.36%	49
2015 Q4	$842K	Sell	27,464 -1,037	-4%	-$32.6K	0.41%	38
2015 Q3	$847K	Buy	28,501 +18,917	+197%	+$607K	0.52%	37
2015 Q2	$305K	Buy	9,584 +2,896	+43%	+$94.4K	0.2%	66
2015 Q1	$220K	Buy	+6,688	New	+$213K	0.14%	83
2014 Q4	–	Sell	-11,934	Closed	-$334K	–	94
2014 Q3	$334K	Buy	+11,934	New	+$335K	0.24%	52

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Signature Financial Management's PFE Position: Q4 2018 in Review

Signature Financial Management reduced its Pfizer (PFE) stake by 70% in Q4 2018, selling an estimated $2.18M and leaving 22,228 shares worth $920K. The position accounts for 0.22% of the portfolio, ranked #49.

Signature Financial Management first reported a position in PFE in Q3 2014 and has held it in 17 quarters since. The position peaked at $3.13M in Q3 2018. 2,404 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

Signature Financial Management held 22,228 shares of Pfizer worth $920K as of Q4 2018.
Signature Financial Management sold 52,633 Pfizer shares in Q4 2018, an estimated $2.18M.
Pfizer made up 0.22% of Signature Financial Management's portfolio in Q4 2018, its #49 holding.
Signature Financial Management first reported a position in Pfizer in Q3 2014 and has held it in 17 quarters since.
Signature Financial Management's Pfizer position peaked at $3.13M in Q3 2018.
2,404 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Signature Financial Management's 13F filing for Q4 2018, filed 13 Feb 2019.